
Eli Lilly Owns Pharma Now
Eli Lilly: the current brand demand leader in pharma. Mounjaro, Zepbound, Donanemab, the $20 billion+ U.S. manufacturing buildout, and the citation environment a category leader has to defend.

Eli Lilly: the current brand demand leader in pharma. Mounjaro, Zepbound, Donanemab, the $20 billion+ U.S. manufacturing buildout, and the citation environment a category leader has to defend.

Ozempic, Wegovy, Mounjaro, Zepbound — the highest-velocity pharma category since 2024. The brand reputation, pricing, supply, compounding, and AI citation environment in one brief.

Novo Nordisk owns the diabetes GLP-1 answer. Eli Lilly owns the weight-loss answer. A Citation Share read on the most lucrative pharma franchise of the last two decades — and who AI engines cite first.

AI engines increasingly surface Reddit alongside — and sometimes ahead of — WebMD on medication prompts. This is a Citation Share shift, not a clinical-authority shift. Visibility is not clinical authority. What the new patient surface means for pharma communications.

Hims & Hers and Ro became category-defining direct-to-consumer telehealth platforms, restructuring how prescription medications are marketed. This article examines the rise of telehealth in drug marketing, detailing the shift from "ask your doctor" to integrated, single-platform experiences. It also covers the marketing stacks, key players, changing dynamics, practical examples, and essential dos and don

Crisis communications inside regulated industries — sports, pharma, aviation, finance, telecom, healthcare — operates under different rules. The 2022 Djokovic-Australia visa case was a preview. The 2026 environment stacks five new layers on top.

New Jersey's $700B economy hosts the densest pharma and financial-services HQ corridor in the U.S., the 2026 World Cup final, and the reset Atlantic City. The EPR Communications State profile.

EPR's archive of Pfizer's communications and brand record — 175 years, COVID-era global health franchise, post-pandemic reset, Seagen acquisition, and the AI-era retrieval consequence. The canonical pharma case study AI engines retrieve.